Biologics
MIIG® 115 Minimally-Invasive Injectable Graft
Injects. Hardens. Replaced By Bone.**
MIIG® Injectable Graft was developed for less invasive treatment in metaphyseal defects with open or closed reduction. The injectable graft hardens inside the body and is receptive to adjunctive hardware.*
Wright Medical's proprietary alpha crystal technology reliably produces a bone graft that performs in contained defects.
MIIG® 115 Graft Design Features
- Injects through small gauge needle
- Hardens in defect
- Completely resorbs**
- Regenerates bone**
* Minimally Invasive Injectable Graft is not a substitute for rigid internal or external fixation.
** Claims are based on critically sized canine defect model at 6 weeks. It is unknown how results from the canine model compare with clinical results in humans.
 |
|
|
